Comparing TNF Pharmaceuticals (TNFA) & The Competition

Profitability This table compares TNF Pharmaceuticals and its rivals’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets TNF Pharmaceuticals N/A -180.71% -84.27% TNF Pharmaceuticals Competitors -2,067.68% -46.11% -27.32% Risk and Volatility TNF Pharmaceuticals has a beta of 2.13, suggesting that its share price is 113% more […]

Leave a Reply

Your email address will not be published.

Previous post Danaher (NYSE:DHR) Raised to “Buy” at StockNews.com
Next post PagerDuty, Inc. (NYSE:PD) Given Consensus Rating of “Hold” by Analysts